Literature DB >> 32124720

Capture and Detection of Plasmodium vivax Lactate Dehydrogenase in a Bead-Based Multiplex Immunoassay.

Eric Rogier1, Doug Nace1, Dragan Ljolje2,1, Naomi W Lucchi1, Venkatachalam Udhayakumar1, Michael Aidoo1.   

Abstract

Laboratory detection of malaria antigens has proved valuable for research and epidemiological purposes. We recently developed a bead-based multiplex antigen assay for pan-Plasmodium and Plasmodium falciparum targets. Here, we report integration of a Plasmodium vivax-specific target to this multiplex panel: P. vivax lactate dehydrogenase (PvLDH). Within the multiplex panel, assay signal for purified PvLDH antigen titrated into the single-digit picogram range. Against a panel of polymerase chain reaction (PCR)-confirmed samples from acute P. vivax infections (n = 36), sensitivity was 91.7% in using PvLDH detection for identifying the presence of parasites. Specificity against a panel of persons with no Plasmodium infection (n = 44) was 100%, and specificity against a panel of PCR-confirmed P. falciparum, Plasmodium malariae, or Plasmodium ovale infections (n = 164) was 90.2%. Addition of this PvLDH capture and detection system into the multiplex antigen panel will now allow for sensitive screening for species identification of both P. falciparum and P. vivax in the laboratory.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32124720      PMCID: PMC7204571          DOI: 10.4269/ajtmh.19-0772

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

Review 1.  Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria.

Authors:  M Gendrot; R Fawaz; J Dormoi; M Madamet; B Pradines
Journal:  Clin Microbiol Infect       Date:  2018-09-27       Impact factor: 8.067

2.  A prospective study from south India to compare the severity of malaria caused by Plasmodium vivax, P. falciparum and dual infection.

Authors:  Shubhanker Mitra; Kpp Abhilash; Shalabh Arora; Angel Miraclin
Journal:  J Vector Borne Dis       Date:  2015-12       Impact factor: 1.688

3.  Assessing Performance of HRP2 Antigen Detection for Malaria Diagnosis in Mozambique.

Authors:  Mateusz M Plucinski; Baltazar Candrinho; Mercia Dimene; James Colborn; Austin Lu; Doug Nace; Rose Zulliger; Eric Rogier
Journal:  J Clin Microbiol       Date:  2019-08-26       Impact factor: 5.948

Review 4.  Use of malaria RDTs in various health contexts across sub-Saharan Africa: a systematic review.

Authors:  Matthew R Boyce; Wendy P O'Meara
Journal:  BMC Public Health       Date:  2017-05-18       Impact factor: 3.295

5.  Bead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic tests.

Authors:  Eric Rogier; Mateusz Plucinski; Naomi Lucchi; Kimberly Mace; Michelle Chang; Jean Frantz Lemoine; Baltazar Candrinho; James Colborn; Rafael Dimbu; Filomeno Fortes; Venkatachalam Udhayakumar; John Barnwell
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

6.  Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection.

Authors:  Mateusz M Plucinski; Peter D McElroy; Pedro Rafael Dimbu; Filomeno Fortes; Doug Nace; Eric S Halsey; Eric Rogier
Journal:  Parasit Vectors       Date:  2019-06-10       Impact factor: 3.876

7.  Characterization of Plasmodium infections among inhabitants of rural areas in Gabon.

Authors:  Tamirat Gebru Woldearegai; Albert Lalremruata; The Trong Nguyen; Markus Gmeiner; Luzia Veletzky; Gildas B Tazemda-Kuitsouc; Pierre Blaise Matsiegui; Benjamin Mordmüller; Jana Held
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

8.  A new highly sensitive enzyme-linked immunosorbent assay for the detection of Plasmodium falciparum histidine-rich protein 2 in whole blood.

Authors:  Ihn Kyung Jang; Smita Das; Rebecca S Barney; Roger B Peck; Andrew Rashid; Stephane Proux; Emmanuel Arinaitwe; John Rek; Maxwell Murphy; Katherine Bowers; Samuel Boadi; Julie Watson; Francois Nosten; Bryan Greenhouse; Peter L Chiodini; Gonzalo J Domingo
Journal:  Malar J       Date:  2018-11-01       Impact factor: 2.979

9.  A saliva-based rapid test to quantify the infectious subclinical malaria parasite reservoir.

Authors:  Dingyin Tao; Brent McGill; Timothy Hamerly; Tamaki Kobayashi; Prachi Khare; Amanda Dziedzic; Tomasz Leski; Andrew Holtz; Bruce Shull; Anne E Jedlicka; Andrew Walzer; Paul D Slowey; Christopher C Slowey; Sandrine E Nsango; David A Stenger; Mike Chaponda; Modest Mulenga; Kathryn H Jacobsen; David J Sullivan; Sadie J Ryan; Rashid Ansumana; William J Moss; Isabelle Morlais; Rhoel R Dinglasan
Journal:  Sci Transl Med       Date:  2019-01-02       Impact factor: 17.956

View more
  3 in total

1.  Symptomatic Plasmodium vivax Infection in Rwanda.

Authors:  Jessica N McCaffery; Tharcisse Munyaneza; Aline Uwimana; Doug Nace; Naomi Lucchi; Eric S Halsey; Eric Rogier
Journal:  Open Forum Infect Dis       Date:  2022-01-19       Impact factor: 3.835

2.  Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic.

Authors:  Laura C Steinhardt; Fehintola Ige; Nnaemeka C Iriemenam; Stacie M Greby; Yohhei Hamada; Mabel Uwandu; Maureen Aniedobe; Kristen A Stafford; Alash'le Abimiku; Nwando Mba; Ndidi Agala; Olumide Okunoye; Augustine Mpamugo; Mahesh Swaminathan; Edewede Onokevbagbe; Temitope Olaleye; Ifeanyichukwu Odoh; Barbara J Marston; McPaul Okoye; Ibrahim Abubakar; Molebogeng X Rangaka; Eric Rogier; Rosemary Audu
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

3.  Plasmodium falciparum pfhrp2 and pfhrp3 Gene Deletions and Relatedness to Other Global Isolates, Djibouti, 2019-2020.

Authors:  Eric Rogier; Jessica N McCaffery; Mohamed Ali Mohamed; Camelia Herman; Doug Nace; Rachel Daniels; Naomi Lucchi; Sophie Jones; Ira Goldman; Michael Aidoo; Qin Cheng; Edie A Kemenang; Venkatachalam Udhayakumar; Jane Cunningham
Journal:  Emerg Infect Dis       Date:  2022-10       Impact factor: 16.126

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.